DANIEL ORR: Open Payments
NPI 1891846614 · CHESTER SPRINGS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,192 in 96 payments from 19 companies in 2025. Trend: 2023 $8,492 · 2024 $2,220 · 2025 $2,192
Food & beverage: $2,180Education: $12
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $373 |
| Axsome Therapeutics, Inc. | 11 | $253 |
| ABBVIE INC. | 13 | $238 |
| Lundbeck LLC | 7 | $159 |
| Neurocrine BioSciences, Inc. | 8 | $158 |
| Amgen Inc. | 10 | $146 |
| Vanda Pharmaceuticals Inc. | 7 | $135 |
| Lilly USA, LLC | 5 | $117 |
| PFIZER INC. | 5 | $114 |
| Novo Nordisk Inc | 4 | $81 |
Products named: CAPLYTA, Auvelity, REXULTI, INGREZZA, FANAPT, MOUNJARO, VRAYLAR, OTEZLA.
Industry payments across PA — which companies pay providers there.
